NEOGENOMICS INC — Director's Dealing 2018

Mar 28, 2018

SEC Form 4/A — Form 4/A

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2018-02-26

Reporting Person: VAN OORT DOUGLAS M (Chairman and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-26	Stock Option (Right to Buy)	$8.03	A	500000	Acquired	2023-02-26	Common Stock (500000.0)	Direct

Footnotes

F1: The number of shares of common stock covered by this stock option grant exceeded a limitation applicable to equity awards under the Amended and Restated Equity Incentive Plan and 136,000 excess options were rescinded. This Amended Form 4 reflects the corrected number of stock options granted. Except as otherwise stated above, the vesting and other terms and conditions of the stock option will remain unchanged.

F2: On February 26, 2018, Mr. VanOort was granted stock options; these stock options vest ratably over the first three anniversary dates of the grant date.